c-Src phosphorylation and activation of hexokinase promotes tumorigenesis and metastasis.
c-Src phosphorylation and activation of hexokinase promotes tumorigenesis and metastasis.
复制标题
c-Src磷酸化和己糖激酶激活促进肿瘤发生和转移
DOI:
10.1038/ncomms13732
复制
发表时间:
2017-01-05
影响因子:
16.6
通讯作者:
Li Q
中科院分区:
文献类型:
--
作者:
Zhang J;Wang S;Jiang B;Huang L;Ji Z;Li X;Zhou H;Han A;Chen A;Wu Y;Ma H;Zhao W;Zhao Q;Xie C;Sun X;Zhou Y;Huang H;Suleman M;Lin F;Zhou L;Tian F;Jin M;Cai Y;Zhang N;Li Q
It is well known that c-Src has important roles in tumorigenesis. However, it remains unclear whether c-Src contributes to metabolic reprogramming. Here we find that c-Src can interact with and phosphorylate hexokinases HK1 and HK2, the rate-limiting enzymes in glycolysis. Tyrosine phosphorylation dramatically increases their catalytic activity and thus enhances glycolysis. Mechanistically, c-Src phosphorylation of HK1 at Tyr732 robustly decreases its K m and increases its V max by disrupting its dimer formation. Mutation in c-Src phosphorylation site of either HK1 or HK2 remarkably abrogates the stimulating effects of c-Src on glycolysis, cell proliferation, migration, invasion, tumorigenesis and metastasis. Due to its lower K m for glucose, HK1 rather than HK2 is required for tumour cell survival when glucose is scarce. Importantly, HK1-Y732 phosphorylation level remarkably correlates with the incidence and metastasis of various clinical cancers and may serve as a marker to predict metastasis risk of primary cancers.